Symic Biomedical Garners $25,000,000 Series A Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d330bb44-61ff-4bd5-b882-f3b89f925878 - Date
12/1/2015 - Company Name
Symic Biomedical - Mailing Address
953 Indiana Street San Francisco, CA 94107 USA - Company Description
Symic Biomedical is developing a new category of therapeutics that offer an exciting and biologically innovative approach to treating disease. - Website
http://www.symicbio.com - Transaction Type
Venture Equity - Transaction Amount
$25,000,000 - Transaction Round
Series A - Proceeds Purposes
We are now well capitalized to move our vascular and osteoarthritis programs through Phase 1/2 studies in the clinic and to continue the exciting research on what our next clinical program will be. - M&A Terms
- Venture Investor
Lilly Ventures - Venture Investor
Undisclosed
